EnglishFrançais EspañolРусский
Search
WecLac® Individual Clinical Strains
Clinically Studied
SCI/Patent Supported

Home > Products > WecLac® Individual Clinical Strains > Bifidobacterium animalis subsp. lactis

Bifidobacterium animalis subsp. lactis BLa80

80.png

Potency

800B CFU/g


Research

20+ Clinical Studies

24+ SCI Papers


Deposit Number

ATCCPTA-126817  DSM35760

CGMCCNo.22547

Functions
  • Digestive Health
  • Maternal & Child Health
  • Gut Health
  • Gastric Health
  • Metabolic Health
  • Liver Health
  • Emotional Health
  • Immune Health
  • Oral Health
Specialization Advantages
  • 40,000+ Strain Resources
  • GRAS certified
  • Allergen free
  • SCI / Patent supported
  • High survivability
  • Non-GMO verified
  • Clinically studied
  • High colonisation
  • Precise function
Industrialization Advantages
  • High potency
  • Low water activity
  • Cost-effectiveness
  • High stability
  • Fast delivery
  • cGMP standard
  • Excellent batch stability
  • Stable supply chain
  • Advanced equipment
Application
  • Dietary Supplement
  • Food
  • Dairy
  • Precision Medicine
  • Personal Care
  • Feed Additive/Pet
WecLac® Individual Clinical Strains
  • Weizmannia coagulans BC99
  • Lacticaseibacillus rhamnosus LRa05
  • Lacticaseibacillus paracasei LC86
  • Bifidobacterium breve BBr60
  • Bifidobacterium longum subsp. longum BL21
  • Pediococcus acidilactici PA53
  • Lactobacillus acidophilus LA85
  • Akkermansia muciniphila Akk11
  • Lactiplantibacillus plantarum Lp05
    • No.999,Guangming Rd., Wujiang Economic and Technological Development Zone, Suzhoum City, Jiangsu Province, China
    Online Message
    Wecare Probiotics
    EnglishFrançais EspañolРусский
    Leave a Message